SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-005399
Filing Date
2016-03-08
Accepted
2016-03-08 17:31:31
Documents
53
Period of Report
2016-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-013116.htm 10-Q 282532
2 AMENDMENT TO EXECUTIVE COMPENSATION AGREEMENT pharmacyte_ex1001.htm EX-10.1 12361
3 AMENDMENT TO EXECUTIVE COMPENSATION AGREEMENT pharmacyte_ex1002.htm EX-10.2 12325
4 STOCK OPTION AGREEMENT pharmacyte_ex1003.htm EX-10.3 29519
5 STOCK OPTION AGREEMENT pharmacyte_ex1004.htm EX-10.4 29790
6 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 9016
7 STATEMENT pharmacyte_ex3201.htm EX-32.1 5726
  Complete submission text file 0001019687-16-005399.txt   2194461

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE pmcb-20160131.xml EX-101.INS 345521
9 XBRL SCHEMA FILE pmcb-20160131.xsd EX-101.SCH 24363
10 XBRL CALCULATION FILE pmcb-20160131_cal.xml EX-101.CAL 39151
11 XBRL DEFINITION FILE pmcb-20160131_def.xml EX-101.DEF 91532
12 XBRL LABEL FILE pmcb-20160131_lab.xml EX-101.LAB 197598
13 XBRL PRESENTATION FILE pmcb-20160131_pre.xml EX-101.PRE 160338
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 161492600
SIC: 2833 Medicinal Chemicals & Botanical Products